Cancer innovation
The biomedical research community has made leaps and bounds in cancer research, clinical trials, diagnostics and treatment. Part of this effort is spearheaded by the National Institutes of Health. Today, the war on cancer continues. Innovation in cancer care requires close attention to technology modernization, system capacities that handle increased data sharing and predictive analytics features, plus ongoing engagement with clinicians and other health care providers to ensure personalized care for all types of cancers throughout all stages from detection to recovery.
New self-sampling technologies screening for HPV could help increase access and reduce cervical cancer among underserved and high-burden populations.
The Surveillance, Epidemiology and End Results Program is kicking off new data initiatives to improve the diagnosis, treatment and outcomes of cancer.
NCI's ANCHOR study discovered that early treatment of precancerous lesions can cut anal cancer rates by more than half in people with HIV.
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
At the end of April, Principal Deputy Director Dr. Douglas Lowy will serve as acting director.
The Wilmot Cancer Institute is looking to AR/VR for data visualization beyond dashboards.
The president wants to further domestic tech innovation and advancements in opioid, mental health, veterans and cancer care.
The White House aims to accelerate cancer research, expand data-sharing, reduce cancer deaths and encourage screenings.
Data, communications tech, next-gen DNA sequencing and more have helped accelerate NCI's mission over the past 50 years.
CIO Jeff Shilling shares how cloud infrastructure is supporting data-sharing across the cancer research community.
In this episode of our National Cancer Act 50th anniversary miniseries, we dive into how NCI is fighting pediatric cancers.
In this latest episode of the National Cancer Act miniseries, we discuss progress in cancer prevention research and practice.
Making the fight against cancer more equitable requires diversifying cancer research, clinical trials and treatments.
Clinical trials, innovation in research and technology have improved cancer treatment and diagnostics in public health.
Emerging data and technology drives new health recommendations to address disease and preventive services.
We delve into the history of cancer in America and talk to NCI Director Dr. Ned Sharpless on NCI's work the past 50 years.
HealthCast dives into the history and progress of legislation that kicked off decades of cancer care research and innovation.
Support for cancer research could see boosts in the new presidential administration.
Technology plays a critical role in addressing significant mental health challenges for cancer patients during the pandemic.
With the help of technology, the agency is addressing international disruptions in cancer care caused by the pandemic.
